{"id":393595,"date":"2025-02-11T00:01:00","date_gmt":"2025-02-10T23:01:00","guid":{"rendered":"https:\/\/medizinonline.com\/sglt-2-i-a-envisager-pour-tous-les-patients-atteints-dirc\/"},"modified":"2025-02-10T21:42:30","modified_gmt":"2025-02-10T20:42:30","slug":"sglt-2-i-a-envisager-pour-tous-les-patients-atteints-dirc","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/sglt-2-i-a-envisager-pour-tous-les-patients-atteints-dirc\/","title":{"rendered":"SGLT-2-i : \u00e0 envisager pour tous les patients atteints d&#8217;IRC"},"content":{"rendered":"\n<p><strong>Le d\u00e9pistage et le traitement pr\u00e9coces de la maladie r\u00e9nale chronique<em> (<\/em> MRC) sont essentiels pour stopper la progression et g\u00e9rer les complications. La d\u00e9termination de l&#8217;albuminurie permet de poser le diagnostic plus t\u00f4t qu&#8217;en se basant uniquement sur le DFGe. Les inhibiteurs du SGLT-2, initialement d\u00e9velopp\u00e9s pour le traitement du diab\u00e8te, ne sont pas seulement cardioprotecteurs, ils permettent \u00e9galement de lutter contre la progression de la perte de la fonction r\u00e9nale.    <\/strong><\/p>\n\n\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fsglt-2-i-a-envisager-pour-tous-les-patients-atteints-dirc%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Le d\u00e9pistage et le traitement pr\u00e9coces de la maladie r\u00e9nale chronique ( MRC) sont essentiels pour stopper la progression et g\u00e9rer les complications. La d\u00e9termination de l&#8217;albuminurie permet de poser&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fsglt-2-i-a-envisager-pour-tous-les-patients-atteints-dirc%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":393600,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Maladie r\u00e9nale chronique  ","footnotes":""},"category":[11549,11378,11315,11434,11535],"tags":[12834,12826,17819,12838,18589],"powerkit_post_featured":[],"class_list":["post-393595","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-fr","category-cardiologie","category-medecine-interne-generale","category-nephrologie-fr","category-rapports-de-congres","tag-albuminurie-fr","tag-ckd-fr","tag-egfr-fr","tag-maladie-renale-chronique","tag-sglt-2-i-fr","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-04-18 13:32:48","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":393673,"slug":"sglt-2-i-considerare-per-tutti-i-pazienti-con-ckd","post_title":"SGLT-2-i: considerare per tutti i pazienti con CKD","href":"https:\/\/medizinonline.com\/it\/sglt-2-i-considerare-per-tutti-i-pazienti-con-ckd\/"},"pt_PT":{"locale":"pt_PT","id":393668,"slug":"sglt-2-i-considere-para-todos-os-doentes-com-drc","post_title":"SGLT-2-i: considere para todos os doentes com DRC","href":"https:\/\/medizinonline.com\/pt-pt\/sglt-2-i-considere-para-todos-os-doentes-com-drc\/"},"es_ES":{"locale":"es_ES","id":393587,"slug":"sglt-2-i-considerar-para-todos-los-pacientes-con-erc","post_title":"SGLT-2-i: considerar para todos los pacientes con ERC","href":"https:\/\/medizinonline.com\/es\/sglt-2-i-considerar-para-todos-los-pacientes-con-erc\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/393595","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=393595"}],"version-history":[{"count":2,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/393595\/revisions"}],"predecessor-version":[{"id":394625,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/393595\/revisions\/394625"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/393600"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=393595"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=393595"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=393595"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=393595"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}